PEPTIDES FOR USE IN THE IMMUNOTHERAPY OF RENAL CELL CARCINOMA

摘要

The present invention relates to peptides for use in immunotherapy of tumors, in particular renal cell carcinoma's. The peptides are derived from the amino acid sequence of a renal cell carcinoma-associated antigen, called the G250 protein. A particularly preferred peptide has the amino acid sequence: HLSTAFARV. The peptides of the invention may be formulated into pharmaceutical composition for administration to humans or animals. Alternatively, the peptides may be administered to a human or animal in conjunction with an antigen presenting cell, or they may be encoded on a gene therapy agent to be expressed by the human or animal.